Comparison of miRNA expression profiles in individuals with chronic or aggressive periodontitis.

OBJECTIVES: MicroRNAs (miRNAs) may play an important role in inflammatory response. However, the involvement of miRNAs in the pathogenesis of periodontitis is unclear. The present study aimed to compare the miRNA expression profiles in individuals with chronic (CP) or aggressive (AP) periodontitis. MATERIALS AND METHODS: Eighteen non-smoker individuals (CP = 9 and AP = 9) without any history of systemic diseases or previous periodontal therapies were selected at the Clinics of Periodontology from the Federal University of Minas Gerais. Gingival tissue samples were collected during the initial periodontal therapy. miRNAs were isolated, and expression patterns of 754 miRNAs were assessed with a quantitative miRNA PCR array. miRNAs expression profiles were compared between CP and AP groups. RESULTS: There were no differences observed in the miRNAs expression profiles between CP and AP (p > 0.05). According to the microarray analyses, the most expressed miRNAs in both groups were hsa-miR-1274b, hsa-let-7b-5p, hsa-miR-24-3p, hsa-miR-19b-3p, hsa-miR-720, hsa-miR-126-3p, hsa-miR-17-3p and hsa-miR-21-3p. CONCLUSION: Findings suggested no differences in miRNAs expression profiles between chronic and aggressive forms of periodontitis. The overexpression of specific miRNAs could provide insights into the pathogenesis of both forms of the disease.

Periodontitis as a risk factor for peri-implantitis: Systematic review and meta-analysis of observational studies.

OBJECTIVES: To evaluate the scientific evidence from observational studies concerning the risk of peri-implantitis development in periodontally-compromised patients. SOURCE: The search was carried out in Medline, via PubMed, and the Cochrane Library up to March 2018. STUDY SELECTION: Clinical studies reporting data on periodontitis and peri-implantitis, with confirmed diagnosis of peri-implantitis based on specific parameters (peri-implant probing depth and peri-implant bleeding on probing) and with evaluations of implants with at least 1 year of function were selected. DATA: Nineteen articles were included; only two did not show any association between periodontitis and peri-implantitis. Quality analysis of the articles revealed a low risk of bias in most of the studies. Meta-analyses by study design on patient data showed that patients with periodontitis had a 2.29 higher risk of peri-implantitis than patients without periodontitis (95%CI: 1.34-3.24). However, the effect estimate was OR 5.15 (95%CI: -3.35; 13.65; I2: 0%, p = 0.887) for cohort studies. A subgroup analysis showed a significant association between peri-implantitis and chronic periodontitis (patient based data: OR = 2.89, 95% CI: 1.79-4.00). Meta-analysis by study design on implant data showed that implants in individuals with periodontitis had 2.15 higher chances of having peri-implantitis (95%CI: 1.10; 3.21). However, the effect estimate was OR 3.24 (95%CI: -0.05; 6.53) for cohort studies. CONCLUSIONS: This systematic review showed that diagnosis or history of periodontitis was associated with the occurrence of peri-implantitis. However, this association was not observed when only the cohort studies were analyzed. Results should be evaluated with caution due to heterogeneity among the included primary studies. Registration number CRD42015009518. CLINICAL SIGNIFICANCE: Peri-implantitis is a prevalent condition and and present an uncertain prognosis. Determining the potential factors associated with peri-implantitis is fundamental for preventive strategies.

Drogas promissoras na reparação óssea periodontal: sinvastatina, ranelato de estrôncio e alendronato de sódio / Promissing drugs for periodontal bone regeneration: simvastatin, strontium ranelate, and sodium alendronate

O tratamento de defeitos ósseos intrabucais tem sido um desafi o na área odontológica, e a pesquisa de novas drogas para otimizar os resultados cirúrgicos regenerativos é de extrema importância. Existem evidências de que algumas drogas, como o ranelato de estrôncio (RSr), a sinvastatina (SNV) e o alendronato de sódio (ALE), têm propriedades anabólicas no metabolismo ósseo. A proposta desta revisão foi apresentar o estado atual da arte sobre o emprego da SNV, do RSr e do ALE em terapias odontológicas. Foi realizada uma busca bibliográfica na base PubMed e incluídos estudos relevantes relacionados ao tema para síntese deste trabalho. Concluiu-se que a aplicação do ALE e da SIN são efetivos como coadjuvantes no tratamento mêcanico da doença periodontal e como indutores de neoformação óssea, entretanto, o RSr merece ser mais bem estudado para tal afirmação.

The treatment of intraoral bone defects has been a challenge in dentistry, in this way the development of new drugs in order to optimize surgical regenerative results are extreme important. There are evidences that drugs such as strontium ranelate (RSr), simvastatin (SNV) and sodium alendronate (ALE) have anabolic properties in bone metabolism and several studies have been performed aiming to improve therapeutic strategies in bone regeneration. Therefore, the purpose of this review is to present the current state of art about the usage of SNV, RSr and ALE in dental therapies, targeting better clinical outcomes in bone manipulation techniques. A literature research was performed in PubMed database and relevant studies between were included. Our study concluded that application of ALE and SNV are effective as adjuncts with mechanical therapy of periodontal disease and also induces bone formation. In the other hand, the application of RSr as a promising bone formation drug needs to be better elucidated.

Stylohyoid complex ossification in temporomandibular disorder: a case-control study.

STATEMENT OF PROBLEM: Stylohyoid complex ossification (SCO) can be associated with temporomandibular disorder (TMD). However, this subject is poorly investigated in epidemiological studies. PURPOSE: The purpose of this study was to assess the association between TMD and SCO. MATERIAL AND METHODS: Seventy-eight individuals with TMD and 93 control individuals without TMD were enrolled in a case-control study and paired according to age and gender. Panoramic radiographs were made of all participants, and SCO was measured in millimeters (mm) by a blinded researcher. Ossification was held to begin at measurements of 30 mm or more. The association between symptoms (pain upon swallowing or turning the head and the sensation of a foreign body in the throat) and SCO was investigated. Pearson chi-square tests were used for the comparison of proportions, (α=.05). RESULTS: A total of 44.9% of those with TMD and 46.2% of the control population exhibited SCO (P=.858). TMD was associated with pain upon swallowing (P<.05) and upon turning the head P<.01), but there were no associations between the symptoms possibly related to SCO and the presence of ossification (pain upon swallowing P=.658; sensation of a foreign body in the throat P=.980; pain upon turning the head P=.405). CONCLUSIONS: The results suggest that there are no associations between TMD and SCO. Some symptoms classically associated with SCO also occur in TMD patients.